Molecular Docking Study of Small Plant-based Molecules for Inhibiting PBP2a Protein in Methicillin-Resistant Staphylococcus aureus (MRSA)

Authors

    Dr. Parvin Shariati * National Institute of Genetic Engineering and Biotechnology (NIGEB) shariati@nigeb.ac.ir
    Mr. Reza Nori National Institute of Genetic Engineering and Biotechnology (NIGEB)
https://doi.org/10.66224/BiotechIntellect.2.1.5

Keywords:

Antibiotic resistance, Methicillin-Resistant Staphylococcus aureus (MRSA), Plant-based compounds, Curcumin, Quercetin, Molecular docking, In silico, Drug discovery

Abstract

Background: Antibiotic resistance, particularly in multidrug-resistant bacteria like Methicillin-Resistant Staphylococcus aureus (MRSA), poses a significant global health risk. The PBP2a protein is the major cause of MRSA resistance to beta-lactam antibiotics. This research was conducted in an "in silico" manner with the aim of identifying novel compounds with putative inhibitory activity against the PBP2a protein to overcome this resistance. The main goal of the article is to use molecular docking to find plant-based compounds that can serve as an alternative to antibiotics and help overcome MRSA bacterial resistance. Materials and Methods: This study was carried out using a descriptive-analytical method and molecular docking. First, the structure of the PBP2a protein and seven plant-based ligands were downloaded from the PDB and PubChem databases, respectively. The ligands included Allicin, Carvacrol, Thymol, Curcumin, Eugenol, Quercetin, and Terpinen-4-ol. For the docking simulation and visualization of the interaction between PBP2a and the ligands, we used Molegro Virtual Docker 6.0 and Molegro Molecular Viewer 2.5 software. Results and Conclusion: The results showed that Curcumin (ligand ID 969516) was bound to the protein with the best MolDock score of -281.131 kJ/mol. Based on its correct positioning and structural analysis, this compound can inhibit the enzymatic activity of PBP2a by binding to its active site. Accordingly, after further clinical studies, this compound is suggested as a suitable candidate for the treatment of MRSA infections. Quercetin (ligand ID 5280343) is also a strong candidate due to its high score of -279.218 kJ/mol. Conflict of interest: The authors declare no conflict of interest

Downloads

Download data is not yet available.

Author Biographies

  • Dr. Parvin Shariati, National Institute of Genetic Engineering and Biotechnology (NIGEB)

    Dr. Parvin Shariati (PhD in Microbiology),

    Assistant Professor,

    National Institute of Genetic Engineering and Biotechnology,

    Institute of Industrial and Environmental Biotechnology,

    Department of Bioprocess Engineering,

    Tehran, Iran

  • Mr. Reza Nori, National Institute of Genetic Engineering and Biotechnology (NIGEB)

    Mr. Reza Nori, Student (Masters),

    National Institute of Genetic Engineering and Biotechnology,

    Institute of Industrial and  Environmental Biotechnology,

    Department of Systems Biotechnology,

    Tehran, 

    Iran

References

1.Milani M, Curia R, Shevlyagina NV, Tatti F. Staphy-lococcus aureus. Bacterial Degradation of Organic and Inorganic Materials: Staphylococcus aureus Meets the Nanoworld: Springer; 2023. p. 3–20. (https://doi.org/ 10.1007/978-3-031-26949-3_1)

2.Fayisa WO, Tuli NF. Review on Staphylococcus aureus. Int J Nurs Care Res. 2023;1:1–8.

(https://www.researchgate.net/profile/Wakgari-Fayisa/publication/378292546_Review_on_Staphylococcus_Aureus/links/65d1d26a01325d465211973a/Review-on-Staphylococcus-Aureus.pdf)

3.Cheung GY, Bae JS, Otto M. Pathogenicity and virulence of Staphylococcus aureus. Virulence. 2021;12(1):547–69. (https://www.tandfonline.com/doi/abs/10.1080/21505594.2021.1878688%4010.1080/tfocoll.2024.0.issue-Virulence-Signature-Series)

4.Salam MA, Al-Amin MY, Salam MT, Pawar JS, Akhter N, Rabaan AA, et al., editors. Antimicrobial resistance: a growing serious threat for global public health. Healthcare; 2023: https://doi.org/10.3390/healthcare11131946

5.Tarin-Pello A, Suay-Garcia B, Perez-Gracia M-T. Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal. Expert review of anti-infective therapy. 2022;20(8):1095–108. (https://doi.org/10.1080/ 14787210.2022.2078308)

6.Baker RE, Mahmud AS, Miller IF, Rajeev M, Rasambainarivo F, Rice BL, et al. Infectious disease in an era of global change. Nature reviews microbiology. 2022;20(4):193–205.(https://doi.org/10.1038/s41579-021-00639-z)

7.Abebe AA, Birhanu AG. Methicillin resistant Staphylococcus aureus: molecular mechanisms underlying drug resistance development and novel strategies to combat. Infection and drug resistance. 2023:7641–62.( https://doi.org/10.2147/IDR.S428103)

8.Belay WY, Getachew M, Tegegne BA, Teffera ZH, Dagne A, Zeleke TK, et al. Mechanism of antibacterial resistance, strategies and next-generation antimicrobials to contain antimicrobial resistance: a review. Frontiers in Pharmacology. 2024;15:1444781. (https://doi.org/10.3389 /fphar.2024.1444781)

9.Darby EM, Trampari E, Siasat P, Gaya MS, Alav I, Webber MA, et al. Molecular mechanisms of antibiotic resistance revisited. Nature Reviews Microbiology. 2023;21(5):280–95. (https://doi.org/10.1038/s41579-022-00820-y)

10. Huang L, Wu C, Gao H, Xu C, Dai M, Huang L, et al. Bacterial multidrug efflux pumps at the frontline of antimicrobial resistance: an overview. Antibiotics. 2022;

11(4):520.(https://doi.org/10.3390/antibiotics11040520)

11. González-Vázquez R, Córdova-Espinoza MG, Escamilla-Gutiérrez A, Herrera-Cuevas MdR, González-Vázquez R, Esquivel-Campos AL, et al. Detection of mecA genes in hospital-acquired MRSA and Sosa strains associated with biofilm formation. Pathogens. 2024;13(3):212. (https://doi.org/10.3390/pathogens 13030212)

12. Aita SE, Ristori MV, Cristiano A, Marfoli T, De Cesaris M, La Vaccara V, et al. Proteomic Insights into Bacterial Responses to Antibiotics: A Narrative Review. International Journal of Molecular Sciences. 2025;26(15):7255.(https://doi.org/10.3390/ijms26157255)

13. Dabhi M, Patel R, Shah V, Soni R, Saraf M, Rawal R, et al. Penicillin-binding proteins: the master builders and breakers of bacterial cell walls and its interaction with β-lactam antibiotics. Journal of Proteins and Proteomics. 2024;15(2):215–32. (https://doi.org/10.1007/s42485-024-00135-x)

14. Paggi JM, Pandit A, Dror RO. The art and science of molecular docking. Annual review of biochemistry. 2024;93(1):389–410. (https://doi.org/10.1146/annurev-biochem-030222-120000)

15. Nguyen TLA, Bhattacharya D. Antimicrobial activity of quercetin: an approach to its mechanistic principle. Molecules.2022;27(8):2494. (https://doi.org/10.3390/molecules27082494)

16. Zhu M, Li Y, Long X, Wang C, Ouyang G, Wang Z. Antibacterial activity of allicin-inspired disulfide derivatives against Xanthomonas axonopodis pv. Citri. International Journal of Molecular Sciences. 2022;23 (19):11947.(https://doi.org/10.3390/ijms231911947)

17. Hajibonabi A, Yekani M, Sharifi S, Nahad JS, Dizaj SM, Memar MY. Antimicrobial activity of nanoformulations of carvacrol and thymol: New trend and applications. OpenNano. 2023;13:100170. (https://doi.org/10.1016/j.onano.2023.100170)

18.Hettiarachchi SS, Perera Y, Dunuweera SP, Dunuweera AN, Rajapakse S, Rajapakse RMG. Comparison of antibacterial activity of nanocurcumin with bulk curcumin. ACS omega. 2022;7(50):46494–500. (https://doi.org/10.1021/acsomega.2c05293)

19.Kowalewska A, Majewska-Smolarek K. Eugenol-based polymeric materials—antibacterial activity and applications. Antibiotics. 2023;12(11): 1570. (https://doi.org/10.3390/antibiotics12111570)

20.Kamiya H, Haraguchi A, Mitarai H, Yuda A, Wada H, Shuxin W, et al. In vitro evaluation of the antimicrobial properties of terpinen-4-ol on apical periodontitis-associated bacteria. Journal of Infection and Chemotherapy. 2024;30(4):306–14. ( https://doi.org/10.1016/j.jiac.2023.10.021)

Molecular Docking for Inhibiting Protein in Resistant S.aureus

Downloads

Published

2025-11-23

Submitted

2024-09-20

Revised

2024-11-19

Accepted

2024-11-22

Issue

Vol. 2 No. 1 (2025): Serial Number 2

Section

Short communication

License

Copyright (c) 2025 Dr. Parvin Shariati; Mr. Reza Nori (Author)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite

Shariati, P., & Nori, R. (2025). Molecular Docking Study of Small Plant-based Molecules for Inhibiting PBP2a Protein in Methicillin-Resistant Staphylococcus aureus (MRSA). BiotechIntellect, 2(1), e16 (1-8). https://doi.org/10.66224/BiotechIntellect.2.1.5

Similar Articles

1-10 of 15

You may also start an advanced similarity search for this article.